Table 2.

Patient laboratory evaluations.

Patient	Ultrasensitive plasma HIV RNA, copies/mL	Peripheral caRNA level, copies/106 PBMCs	Lymph node caRNA level, copies/106 LNMCs	Peripheral pvDNA level, copies/106 CD8-depleted PBMCs	Lymph node pvDNA level, copies/106 LNMCs	Resistance demonstrated by OLA	Resistance demonstrated by TRUGENE
1	5	<50	ND	48	NA	None	ND
2	<1	<50	<50	6	NA	Low peripheral levels of M184V	ND
3	1	<50	<50	81	800	None	None
4	<1	<50	<50	292	60	None	ND

NOTE. caRNA, cell-associated human immunodeficiency virus (HIV) RNA; LNMCs, lymph node mononuclear cells; NA, not amplifiable with polymerase chain reaction, given several attempts; ND, not determined, insufficient sample to assay; OLA, oligonucleotide ligation assay; PBMCs, peripheral blood mononuclear cells; pvDNA, proviral HIV DNA; TRUGENE, genotypic resistance assay (Visible Genetics).